Search Results

There are 6092 results for: content related to: Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function

  1. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 861–881, Manuel Delgado-Alvarado, Belén Gago, Irene Navalpotro-Gomez, Haritz Jiménez-Urbieta and María C. Rodriguez-Oroz

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26662

  2. The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1080–1094, Raul Martínez-Fernández, Emmanuelle Schmitt, Pablo Martinez-Martin and Paul Krack

    Version of Record online : 19 JUL 2016, DOI: 10.1002/mds.26731

  3. The focal dystonias: Current views and challenges for future research

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 926–943, H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen and for the Dystonia Coalition Investigators

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25567

  4. Neuropathology of multiple system atrophy: New thoughts about pathogenesis

    Movement Disorders

    Volume 29, Issue 14, December 2014, Pages: 1720–1741, Kurt A. Jellinger

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26052

  5. You have free access to this content
    The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease

    Movement Disorders

    Volume 31, Issue 1, January 2016, Pages: 23–38, Gretchen O. Reynolds, Michael W. Otto, Terry D. Ellis and Alice Cronin-Golomb

    Version of Record online : 30 DEC 2015, DOI: 10.1002/mds.26484

  6. Biomarkers for trials of neuroprotection in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 71–85, Pankaj A. Agarwal and A. Jon Stoessl

    Version of Record online : 24 AUG 2012, DOI: 10.1002/mds.25065

  7. The anatomical basis of dystonia: Current view using neuroimaging

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 944–957, Stéphane Lehéricy, Marina A.J. Tijssen, Marie Vidailhet, Ryuji Kaji and Sabine Meunier

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25527

  8. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide

    Movement Disorders

    Volume 28, Issue 9, August 2013, Pages: 1184–1199, Maria Stamelou, Niall P. Quinn and Kailash P. Bhatia

    Version of Record online : 29 MAY 2013, DOI: 10.1002/mds.25509

  9. Behavioral effects of levodopa

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 90–102, Isabelle Beaulieu-Boire and Anthony E. Lang

    Version of Record online : 9 DEC 2014, DOI: 10.1002/mds.26121

  10. Psychiatric issues in cognitive impairment

    Movement Disorders

    Volume 29, Issue 5, 15 April 2014, Pages: 651–662, Dag Aarsland, John-Paul Taylor and Daniel Weintraub

    Version of Record online : 22 APR 2014, DOI: 10.1002/mds.25873

  11. The spectrum of cognitive impairment in Lewy body diseases

    Movement Disorders

    Volume 29, Issue 5, 15 April 2014, Pages: 608–621, Jennifer G. Goldman, Caroline Williams-Gray, Roger A. Barker, John E. Duda and James E. Galvin

    Version of Record online : 22 APR 2014, DOI: 10.1002/mds.25866

  12. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases—From pathophysiology to clinical practice

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 836–847, Kaj Blennow, Leonardo Biscetti, Paolo Eusebi and Lucilla Parnetti

    Version of Record online : 4 MAY 2016, DOI: 10.1002/mds.26656

  13. Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?

    Movement Disorders

    Volume 28, Issue 4, April 2013, Pages: 425–438, Gordon W. Duncan, Michael J. Firbank, John T. O'Brien and David J. Burn

    Version of Record online : 28 FEB 2013, DOI: 10.1002/mds.25352

  14. Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease

    Movement Disorders

    Volume 30, Issue 8, July 2015, Pages: 1014–1025, Marc Deffains and Hagai Bergman

    Version of Record online : 22 JUN 2015, DOI: 10.1002/mds.26300

  15. Probing striatal microcircuitry to understand the functional role of cholinergic interneurons

    Movement Disorders

    Volume 30, Issue 10, September 2015, Pages: 1306–1318, Allison E. Girasole and Alexandra B. Nelson

    Version of Record online : 30 JUL 2015, DOI: 10.1002/mds.26340

  16. Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?

    Movement Disorders

    Volume 29, Issue 11, 15 September 2014, Pages: 1404–1413, Annie Killoran and Kevin M. Biglan

    Version of Record online : 27 AUG 2014, DOI: 10.1002/mds.26014

  17. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

    Movement Disorders

    Volume 31, Issue 4, April 2016, Pages: 436–457, Connie Marras, Anthony Lang, Bart P. van de Warrenburg, Carolyn M. Sue, Sarah J. Tabrizi, Lars Bertram, Saadet Mercimek-Mahmutoglu, Darius Ebrahimi-Fakhari, Thomas T. Warner, Alexandra Durr, Birgit Assmann, Katja Lohmann, Vladimir Kostic and Christine Klein

    Version of Record online : 15 APR 2016, DOI: 10.1002/mds.26527

  18. What can biomarkers tell us about cognition in Parkinson's disease?

    Movement Disorders

    Volume 29, Issue 5, 15 April 2014, Pages: 622–633, Brit Mollenhauer, Lynn Rochester, Alice Chen-Plotkin and David Brooks

    Version of Record online : 22 APR 2014, DOI: 10.1002/mds.25846

  19. The neurobiological basis of cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 29, Issue 5, 15 April 2014, Pages: 634–650, Glenda M. Halliday, James B. Leverenz, Jay S. Schneider and Charles H. Adler

    Version of Record online : 22 APR 2014, DOI: 10.1002/mds.25857

  20. Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors

    Movement Disorders

    Volume 28, Issue 11, 15 September 2013, Pages: 1544–1551, Fay B. Horak and Martina Mancini

    Version of Record online : 16 OCT 2013, DOI: 10.1002/mds.25684